Notice2024-01290

Center for Scientific Review; Notice of Closed Meetings

Primary source

Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.

Published
January 24, 2024

Issuing agencies

Health and Human Services DepartmentNational Institutes of Health

Full Text

<html>
<head>
<title>Federal Register, Volume 89 Issue 16 (Wednesday, January 24, 2024)</title>
</head>
<body><pre>
[Federal Register Volume 89, Number 16 (Wednesday, January 24, 2024)]
[Notices]
[Pages 4610-4611]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2024-01290]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Notice of Closed Meetings

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Member Conflict: Topics in Biobehavioral Processes.
    Date: February 15, 2024.
    Time: 10:00 a.m. to 8:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Jeanne M. McCaffery, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Bethesda, MD 20892, 301-594-3854, 
<a href="/cdn-cgi/l/email-protection#95fff0f4fbfbf0bbf8f6f6f4f3f3f0e7ecd5fbfcfdbbf2fae3"><span class="__cf_email__" data-cfemail="c0aaa5a1aeaea5eeada3a3a1a6a6a5b2b980aea9a8eea7afb6">[email&#160;protected]</span></a>.

    Name of Committee: Biological Chemistry and Macromolecular 
Biophysics Integrated Review Group; Chemical Biology and Probes 
Study Section.
    Date: February 15-16, 2024.
    Time: 10:00 a.m. to 8:30 p.m.
    Agenda: To review and evaluate grant applications.

[[Page 4611]]

    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Michael Eissenstat, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 4166, MSC 7806, Bethesda, MD 
20892, (301) 435-1722, <a href="/cdn-cgi/l/email-protection#07626e74746269747366736a664764747529696e6f29606871"><span class="__cf_email__" data-cfemail="6d08041e1e08031e190c19000c2d0e1e1f43030405430a021b">[email&#160;protected]</span></a>.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Academic-Industrial Partnerships for Translation of 
Technologies.
    Date: February 15-16, 2024.
    Time: 10:00 a.m. to 8:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Jennifer Ann Sanders, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 496-3553, 
<a href="/cdn-cgi/l/email-protection#adc7c8c3c3c4cbc8df83deccc3c9c8dfdeedc3c4c583cac2db"><span class="__cf_email__" data-cfemail="69030c0707000f0c1b471a08070d0c1b1a29070001470e061f">[email&#160;protected]</span></a>.

    Name of Committee: Genes, Genomes, and Genetics Integrated 
Review Group; Genetic Variation and Evolution Study Section.
    Date: February 15-16, 2024.
    Time: 10:00 a.m. to 8:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892 (Hybrid Meeting).
    Contact Person: Guoqin Yu, Ph.D,. Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Bethesda, MD 20892, (301) 435-1276, 
<a href="/cdn-cgi/l/email-protection#1e796b716f777030676b5e70777630797168"><span class="__cf_email__" data-cfemail="bed9cbd1cfd7d090c7cbfed0d7d690d9d1c8">[email&#160;protected]</span></a>.

    Name of Committee: Population Sciences and Epidemiology 
Integrated Review Group; Social Sciences and Population Studies B 
Study Section.
    Date: February 15-16, 2024.
    Time: 10:30 a.m. to 9:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Kate Fothergill, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 3142, Bethesda, MD 20892, 301-
435-2309, <a href="/cdn-cgi/l/email-protection#3b5d544f535e495c525757505e7b565a525715555253155c544d"><span class="__cf_email__" data-cfemail="a9cfc6ddc1ccdbcec0c5c5c2cce9c4c8c0c587c7c0c187cec6df">[email&#160;protected]</span></a>.

    Name of Committee: Integrative, Functional and Cognitive 
Neuroscience Integrated Review Group; Neurobiology of Pain and Itch 
Study Section.
    Date: February 20-21, 2024.
    Time: 9:00 a.m. to 8:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Anne-Sophie Marie Lucie Wattiez, Ph.D., 
Scientific Review Officer, Center for Scientific Review, National 
Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, 
(301) 594-4642, <a href="/cdn-cgi/l/email-protection#9dfcf3f3f8b0eef2edf5f4f8b3eafce9e9f4f8e7ddf3f4f5b3faf2eb"><span class="__cf_email__" data-cfemail="a0c1cecec58dd3cfd0c8c9c58ed7c1d4d4c9c5dae0cec9c88ec7cfd6">[email&#160;protected]</span></a>.

    Name of Committee: Healthcare Delivery and Methodologies 
Integrated Review Group Health Promotion in Communities Study 
Section.
    Date: February 20-21, 2024.
    Time: 9:00 a.m. to 8:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Helena Eryam Dagadu, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 3137, Bethesda, MD 20892, (301) 
435-1266, <a href="/cdn-cgi/l/email-protection#85e1e4e2e4e1f0ede0c5e6f6f7abebecedabe2eaf3"><span class="__cf_email__" data-cfemail="4c282d2b2d283924290c2f3f3e62222524622b233a">[email&#160;protected]</span></a>.

    Name of Committee: Applied Immunology and Disease Control 
Integrated Review Group; Transmission of Vector-Borne and Zoonotic 
Diseases Study Section.
    Date: February 20-21, 2024.
    Time: 9:00 a.m. to 8:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Haruhiko Murata, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Bethesda, MD 20892, 301-594-3245, 
<a href="/cdn-cgi/l/email-protection#066b73746772676e4665757428686f6e28616970"><span class="__cf_email__" data-cfemail="137e66617267727b537060613d7d7a7b3d747c65">[email&#160;protected]</span></a>.

    Name of Committee: Biology of Development and Aging Integrated 
Review Group; Mechanisms of Cancer Therapeutics A Study Section.
    Date: February 20-21, 2024.
    Time: 9:00 a.m. to 8:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Careen K. Tang-Toth, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 6214, MSC 7804, Bethesda, MD 
20892, (301)435-3504, <a href="/cdn-cgi/l/email-protection#5c283328343f281c3f2f2e72323534723b332a"><span class="__cf_email__" data-cfemail="4b3f243f23283f0b28383965252223652c243d">[email&#160;protected]</span></a>.

    Name of Committee: Oncology 1--Basic Translational Integrated 
Review Group; Cancer Genetics Study Section.
    Date: February 20-21, 2024.
    Time: 9:30 a.m. to 8:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Juraj Bies, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 4158, MSC 7806, Bethesda, MD 20892, 301 435 
1256, <a href="/cdn-cgi/l/email-protection#c5a7aca0b6af85a8a4aca9ebabacadeba2aab3"><span class="__cf_email__" data-cfemail="c2a0aba7b1a882afa3abaeecacabaaeca5adb4">[email&#160;protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, 
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, 
National Institutes of Health, HHS)

    Dated: January 18, 2024.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-01290 Filed 1-23-24; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
Indexed from Federal Register on January 24, 2024.

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.